| Income Statement | 2025-09-30 | |||
|---|---|---|---|---|
| Revenues | 81 | |||
| Cost of sales | 64 | |||
| Research and development | 5 | |||
| General and administrative | 1,004 | |||
| Total operating expenses | 1,073 | |||
| Operating loss | -992 | |||
| Foreign exchange gains (losses) | -14 | |||
| Interest income (expense) | 9 | |||
| Other income, net | 9 | |||
| Total other income, net | 4 | |||
| Loss before taxes | -988 | |||
| Net loss | -988 | |||
| Dividend on convertible exchangeable preferred shares | 21 | |||
| Deemed dividend on warrant exchange | -1,494 | |||
| Net loss applicable to common shareholders | -2,503 | |||
| Net loss per share - basic (common shareholders) | -1.31 | |||
| Net loss per share, diluted | -1.31 | |||
| Weighted average common shares outstanding - basic | 1,912,495 | |||
| Weighted average common shares outstanding - diluted | 1,912,495 | |||
Bio Green Med Solution, Inc. (BGMSP)
Bio Green Med Solution, Inc. (BGMSP)